Table 1.

Nanobiopolymer versions, their sizes, and ζ potentials

Nanobiopolymer variantVersionSize, nmζ potential, mV
P/mPEG/LOEt/AON/Herceptin/TfR(M)Lead version with AON, Herceptin, and anti-TfR(M)22.1 ± 2.3−5.2 ± 0.4
P/mPEG/LOEt/AON/TfR(H/M)With AON and anti-TfR(H/M)20.1 ± 2.4−5.7 ± 0.6
P/mPEG/LOEt/HerceptinWith Herceptin alone15.1 ± 1.2−4.1 ± 0.4
P/mPEG/LOEt/IgGControl version for imaging study with IgGN/AN/A

N/A, Not applicable.